A New Push for Homegrown Medical Isotopes

A nuclear tech firm from Albuquerque is taking steps to build a production site near Eunice, New Mexico. Its goal is to create isotopes that hospitals rely on for scans and treatments. Right now, the U. S. gets all its Molybdenum-99 from old reactors overseas. That supply isn’t stable—if something goes wrong with those reactors, hospitals may have to postpone scans or treatments. This new facility could eventually handle half of the world’s demand for Mo-99, though isotopes can’t be stored for long, so production has to match use hour by hour.The company plans to expand beyond Mo-99 too. Each year, it aims to produce 3. 5 million doses of isotopes used in cancer care. Current research backs this up—there are already over 90 clinical trials testing treatments that could use these isotopes. Moving the material quickly is key: after landing at a processing plant, it has to reach patients in under 36 hours. Getting this complex up and running by 2030 will mean clearing regulatory hurdles and lining up enough money. Securing funding on time is the biggest worry right now. Still, the project’s design leans on proven tech from a national lab, which lowers the risk that new systems might fail. If everything falls into place, this site could reshape how the U. S. sources critical medical supplies.